Topics

Human medicines European public assessment report (EPAR): Naglazyme, galsulfase, Mucopolysaccharidosis VI, Date of authorisation: 23/01/2006, Revision: 14, Status: Authorised

13:24 EDT 14 Aug 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Naglazyme, galsulfase, Mucopolysaccharidosis VI, Date of authorisation: 23/01/2006, Revision: 14, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Naglazyme, galsulfase, Mucopolysaccharidosis VI, Date of authorisation: 23/01/2006, Revision: 14, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Naglazyme, galsulfase, Mucopolysaccharidosis VI, Date of authorisation: 23/01/2006, Revision: 14, Status: Authorised"

Quick Search